Senior insider sale
Chief Financial Officer at BIOAGE LABS, INC. — senior position signals high conviction
$531.8K
27K shares
What this filing means
GOLDSTEIN DOV A MD plans to sell 27K shares of BIOAGE LABS, INC. valued at approximately $531.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/13/2026ACC: 0001959173-26-000287
Officer· Chief Financial Officer
Since Mar 2026
27K
Shares to sell
$531.8K
Approx. market value
27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Granted - 04/17/2024
Cash
1/13/2026
27KTotal acquired27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2026 | Option Granted - 04/17/2024 Cash | 27K | — |
| Total | 27K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
27K
Market value
$531.8K
1/13/2026
Total
Units
27K
Value
$531.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/13/2026 | 27K | $531.8K | NASDAQ | Planned |
| Total | 27K | $531.8K | ||